Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linjie Zhao

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Cell Reports|June 11, 2026
Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cellsChunyu Jin, Linjie Zhao, Wubin Ma, et al.
Molecular Cancer|August 2, 2018
Epigenetics in ovarian cancer: premise, properties, and perspectivesQilian Yang, Yuqing Yang, Nianxin Zhou, et al.
Cancer Discovery|January 9, 2026
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical CancerChunyan Lan, Peidong Zhang, Jing Zhao, et al.
Molecular Cell|February 19, 2022
A FBXO7/EYA2-SCF<sup>FBXW7</sup> axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cellsJia Z Shen, Zhixin Qiu, Qiulian Wu, et al.
Iscience|August 31, 2020
Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade TherapyShuang Huang, Nianxin Zhou, Linjie Zhao, et al.
The Journal of Clinical Investigation|January 2, 2026
Glioblastoma stem cells resist cuproptosis with circadian variation of copper levelsFanen Yuan, Xujia Wu, Huairui Yuan, et al.
Oncotarget|November 27, 2016
LncRNAs: the bridge linking RNA and colorectal cancerYanfei Yang, Linjie Zhao, Lingzi Lei, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2018
Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasisLinjie Zhao, Shuang Huang, Shenglin Mei, et al.
Developmental Cell|June 6, 2022
PDGF signaling inhibits mitophagy in glioblastoma stem cells through N<sup>6</sup>-methyladenosineDeguan Lv, Ryan C Gimple, Cuiqing Zhong, et al.
Nature|May 17, 2023
Lysine catabolism reprograms tumour immunity through histone crotonylationHuairui Yuan, Xujia Wu, Qiulian Wu, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Cell Reports|June 11, 2026
Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cellsChunyu Jin, Linjie Zhao, Wubin Ma, et al.
Molecular Cancer|August 2, 2018
Epigenetics in ovarian cancer: premise, properties, and perspectivesQilian Yang, Yuqing Yang, Nianxin Zhou, et al.
Cancer Discovery|January 9, 2026
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical CancerChunyan Lan, Peidong Zhang, Jing Zhao, et al.
Molecular Cell|February 19, 2022
A FBXO7/EYA2-SCF<sup>FBXW7</sup> axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cellsJia Z Shen, Zhixin Qiu, Qiulian Wu, et al.
Iscience|August 31, 2020
Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade TherapyShuang Huang, Nianxin Zhou, Linjie Zhao, et al.
The Journal of Clinical Investigation|January 2, 2026
Glioblastoma stem cells resist cuproptosis with circadian variation of copper levelsFanen Yuan, Xujia Wu, Huairui Yuan, et al.
Oncotarget|November 27, 2016
LncRNAs: the bridge linking RNA and colorectal cancerYanfei Yang, Linjie Zhao, Lingzi Lei, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2018
Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasisLinjie Zhao, Shuang Huang, Shenglin Mei, et al.
Developmental Cell|June 6, 2022
PDGF signaling inhibits mitophagy in glioblastoma stem cells through N<sup>6</sup>-methyladenosineDeguan Lv, Ryan C Gimple, Cuiqing Zhong, et al.
Nature|May 17, 2023
Lysine catabolism reprograms tumour immunity through histone crotonylationHuairui Yuan, Xujia Wu, Qiulian Wu, et al.
Pageof 10